Probiotics Complete Guide: Strains, CFU, and What…

Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. This definition from the WHO and FAO distinguishes probiotics from the broader category of fermented foods and sets a high bar: the organisms must be alive at the time of consumption, present in sufficient quantities, and supported by evidence of specific health benefits. The probiotic market is crowded with products making broad claims, which makes understanding the science behind specific strains and doses essential for getting actual results from supplementation.

The Importance of Strain Specificity

Probiotics are not interchangeable. Health effects are strain-specific — meaning that evidence for Lactobacillus rhamnosus GG does not apply to Lactobacillus rhamnosus NCIMB 30174 or any other L. rhamnosus strain. The genus and species (e.g., Lactobacillus rhamnosus) convey taxonomic classification; the strain designation (GG, ATCC 53103, etc.) identifies the specific organism with a particular genetic makeup and demonstrated effects. When evaluating a probiotic, always look for the full strain designation, not just genus and species. A product labeled simply "Lactobacillus acidophilus" without a strain identifier cannot be evaluated against the published literature.

Well-Researched Strains and Their Evidence

Lactobacillus rhamnosus GG (LGG) is arguably the best-studied probiotic strain in the world, with over 800 clinical trials. Its evidence base includes prevention and treatment of antibiotic-associated diarrhea, reduction of pediatric diarrhea duration, and emerging data for IBS, eczema prevention, and respiratory infections. Dosing in studies ranges from 1 to 100 billion CFU daily. Saccharomyces boulardii CNCM I-745 is a probiotic yeast (not a bacterium) with exceptional evidence for prevention of antibiotic-associated diarrhea and Clostridioides difficile recurrence. Unlike bacterial probiotics, it is not inhibited by antibiotics, making it particularly valuable during and after antibiotic treatment. Dosing is 250-500 mg (approximately 5-10 billion CFU equivalent) twice daily. Bifidobacterium infantis 35624 has strong evidence for IBS symptom reduction, particularly abdominal pain, bloating, and bowel habit normalization. Lactobacillus acidophilus NCFM reduces abdominal pain in IBS. Lactobacillus plantarum 299v improves gas and bloating in IBS.

CFU Counts: How Much Is Enough?

CFU (colony-forming units) represent the number of viable, live bacteria or organisms per dose. More is not always better — effective doses are strain-specific and range from 1 billion CFU (for some Bifidobacterium strains) to 50-100 billion CFU (for some IBS and IBD protocols). Products with 50-100 billion CFU are appropriate for acute indications (C. diff prevention, antibiotic diarrhea); 10-25 billion CFU is typical for daily maintenance supplementation. CFU counts are only meaningful at the time of consumption — many products lose viability before their expiration date if not stored properly. Look for products that guarantee CFU at expiration (not just at manufacture) and that require refrigeration or are specifically tested for room-temperature stability.

Targeted Probiotic Selection by Condition

For IBS: L. plantarum 299v, B. infantis 35624, and L. rhamnosus GG have the strongest IBS evidence. For antibiotic-associated diarrhea: S. boulardii CNCM I-745 and L. rhamnosus GG. For H. pylori eradication support: L. reuteri DSM 17938 and S. boulardii. For vaginal health: L. rhamnosus GR-1 and L. reuteri RC-14 (specifically formulated vaginal or oral products). For IBD (ulcerative colitis): VSL#3 (now Visbiome), a high-potency 8-strain blend at 450 billion CFU, is the only probiotic with RCT evidence for IBD maintenance. For traveler's diarrhea prevention: S. boulardii CNCM I-745, started 5 days before travel.

Prebiotic and Synbiotic Considerations

Probiotics work best when the gut environment supports their colonization. Prebiotic fiber (FOS, GOS, inulin, resistant starch) feeds beneficial bacteria and supports probiotic survival and activity in the gut. Synbiotics — products combining probiotics and prebiotics — show superior outcomes compared to probiotics alone in some studies. For individuals eating a low-fiber diet, adding a prebiotic supplement or increasing dietary fiber intake amplifies probiotic benefits. However, some individuals with SIBO, IBS-D, or histamine intolerance find that prebiotic fiber worsens symptoms; in these cases, probiotics without added prebiotics are better tolerated initially.

Storage and Product Quality

Probiotic viability is sensitive to heat, moisture, and oxygen. Most lactobacilli and bifidobacteria require refrigeration to maintain potency through their shelf life. S. boulardii and select spore-forming bacteria (Bacillus coagulans, Bacillus subtilis) are more stable at room temperature. Third-party testing by organizations like ConsumerLab, NSF International, or USP verifies that products contain what they label and meet contamination standards. Enteric-coated capsules protect acid-sensitive strains from gastric destruction, improving delivery to the small intestine.

FAQ

Should I take probiotics on an empty stomach or with food? Most strains survive better when taken with food, as the buffering effect of a meal reduces stomach acid pH. Some manufacturers recommend taking probiotics 30 minutes before eating or with a meal. S. boulardii and spore-forming bacteria are more tolerant of acid and can be taken either way. Follow manufacturer recommendations for specific products.

How long before I notice benefits from a probiotic? For acute conditions like antibiotic-associated diarrhea, benefits may be apparent within days. For chronic conditions like IBS, significant improvement typically requires 4-8 weeks of consistent use. Microbiome composition changes measurably within 1-2 weeks but stabilizes over longer periods. Give any probiotic at least 4-6 weeks before assessing efficacy.

Can I take multiple probiotic strains together? Yes, and multi-strain probiotics often show superior outcomes to single-strain products in head-to-head studies, likely because different strains colonize different niches and exert complementary effects. However, the key is ensuring each individual strain is present in an evidence-based dose — a product with 50 strains at 1 billion CFU total is likely providing too little of any individual strain to be effective.

Track your supplements in Optimize.

Probiotics Complete Guide: Strains, CFU, and What Research Shows